Fushine(SZ:300497) Zheng Quan Zhi Xing·2025-08-26 16:35Core Viewpoint - Jiangxi Fuxiang Pharmaceutical Co., Ltd. has reported on non-operating fund occupation and other related fund transactions for the first half of 2025, highlighting significant amounts involved in both non-operating and operating transactions [1]. Summary by Category Non-Operating Fund Occupation - The total amount of non-operating fund occupation as of June 2025 is reported to be 792,693,994.23 yuan, with a cumulative occurrence amount of 795,383,299.54 yuan [2]. - The company has identified various related parties, including controlling shareholders and subsidiaries, with significant balances in non-operating fund occupations [2]. Related Fund Transactions - The report details various related fund transactions, including amounts owed to and from subsidiaries, with a total of 714,353,787.84 yuan in outstanding balances as of June 2025 [2]. - Specific subsidiaries such as Jiangxi Xiangtai Life Science Co., Ltd. and Fuxiang (Shandong) New Materials Co., Ltd. have notable amounts in non-operating fund transactions, indicating a complex financial relationship within the group [2]. Operating Fund Transactions - The report also includes operating fund transactions, with various subsidiaries reporting accounts receivable and payable, indicating ongoing business activities [2]. - The total amount of operating fund transactions reflects the company's active engagement in its core business operations, with significant figures reported for accounts receivable across multiple subsidiaries [2].